The University of Rhode Island's Ryan Institute for Neuroscience is set to begin a pioneering trial of a new drug to treat Alzheimer's disease. Executive director Paula Grammas, associate director William Renehan and clinical programs coordinator Christine Getter discuss the trial -- and the role of inflammation in the currently incurable and invariably fatal disease affecting millions of Americans. Podcast by Providence Journal Staff Writer G. Wayne Miller.

<p>The University of Rhode Island's Ryan Institute for Neuroscience is set to begin a pioneering trial of a new drug to treat Alzheimer's disease. Executive director Paula Grammas, associate director William Renehan and clinical programs coordinator Christine Getter discuss the trial -- and the role of inflammation in the currently incurable and invariably fatal disease affecting millions of Americans. Podcast by Providence Journal Staff Writer G. Wayne Miller.</p>

A collection of interviews,  press conferences and news actualities from the Newsroom of the Providence Journal, Providence, Rhode Island.

News interviews and actualities from  The Providence Journal

From the Newsroom: The Providence Journal

A collection of interviews,  press conferences and news actualities from the Newsroom of the Providence Journal.

Advertisement